Navigation Links
Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Date:12/9/2008

& Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the results of the Phase 2b clinical trial of APD125, including the significance of such results; the further analysis of the Phase 2b clinical trial results and the future development of APD125; the development, therapeutic indication, tolerability, side effects, efficacy and potential of lorcaserin; future activities and announcements relating to lorcaserin, including the BLOOM results and the submission of a New Drug Application for lorcaserin; Arena's R&D Day; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with th
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Critical Pharmaceuticals Enter Sustained Release hGH Arena
2. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
3. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
7. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
8. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
9. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
10. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
11. Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Pomerantz ... investigating claims on behalf of investors of Intuitive Surgical, ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive Surgical common ... (the "Class Period"). Such investors are advised to contact ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. The ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
(Date:5/22/2013)... Mass. and TORONTO , ... ) (OTCBB: GNBT) today announced three presentations demonstrating the ... by its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... meeting of the American Society of Clinical Oncology (ASCO) ... from May 31 through June 4, 2013. ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
... Apollo Endosurgery, Inc. announced that their newly-launched OverStitch™ ... several, first-in-human cases. ... that mimics the way physicians deploy sutures by hand. ... delivering surgical standard of care through the flexible endoscope. ...
... 28 Danaher Corporation (NYSE: DHR ) announced ... Comas will be presenting at the Goldman Sachs Global Industrials ... at 10:15 a.m. EDT. The company also announced that President ... presenting at the Robert W. Baird Industrial Conference in Chicago, ...
Cached Medicine Technology:Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System 2
(Date:5/23/2013)... Nashville, TN (PRWEB) May 23, 2013 ... to enhance nurse understanding of the professional role and ... , Roland Joy, vice president of patient care services ... explains, "TAMC nurses are excellent clinicians, and we want ... profession, teach them that to lead they must follow, ...
(Date:5/23/2013)... PhD Box has introduced a ... the research process by offering assistance for Thesis Proposals. The ... of services that the company provides for research consultation in ... dedicated proposal writing service is that this is the stage ... research process find it difficult to draft a proposal as ...
(Date:5/23/2013)... Following the recent outbreak of fake ... the security team at idcloak Technologies has identified a ... or any web-born malware. Gill-Chris Welles of the ... better privacy and security than traditional antivirus ... the best AV software cannot be depended on: it ...
(Date:5/23/2013)... When Teachers Notebook reached out to its teacher ... the Moore, OK tornado victims, they hoped to attract ... be sold for around $10.00 with all proceeds benefiting ... were overwhelmed by the response from these dedicated educators ... the first 12 hours of the campaign. , Later ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global critical ... number of players accounting for a major proportion of the ... rate between 2006 and 2012, possibly due to the lack ... especially in the US. , GBI Research estimates that ... in 2012, having grown in size at a CAGR of ...
Breaking Medicine News(10 mins):Health News:OnSomble, Inc. Partners with The Aroostook Medical Center to Enhance Nurse Understanding of the Professional Role 2Health News:PhD Box Unveils Proposal Writing Services for Research Scholars 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2
... no open choices. But does this also mean no end-of life ... The department of health recently spoke of 60% compliance of ... elderly. ,To research into this lofty claim, a survey ... lives, often die a lonely death. Nearly 50% of the 800 ...
... this bit of news sent you into an instant cardio-vascular ... soil and the rest, who probably don’t engage// in heart ... ill health. This region portraying a high incidence of cardiovascular ... ,A major health initiative is taking shape under the ...
... can be treated in a short time if diagnosed properly. ... Body CT, the ultrasound technology could be used to accurately ... ,One condition that many runners seek treatment for ... the heel, caused by the back of the shoe consistently ...
... weighed less than 1lb 6oz. He was so weak that he ... ensured that he lived and grew stronger. //Even his mother Donna ... had to be given blood transfusions to recover. ,Now ... those who helped them, they are launching a campaign to fill ...
... has said that suicide rates in Sri Lanka has increased in ... yellow oleander plants even for the most trivial reasons. ... all over the island. It has yellow trumpet-like flowers and a ... seed and one of these seeds is enough to kill you, ...
... million Australians have diabetes. New South Wales (NSW) has recorded ... over the past 10 years. Experts have asked the health ... diabetes. Sooner if it continues it is expected that about ... reason for this increase is that of the diet and ...
Cached Medicine News:Health News:Hush…..A Deadly Killer on the Prowl in Rural Andhra Pradesh 2Health News:Proper Diagnosis Could Augment Speedy Recovery Of Haglund’s Syndrom 2Health News:Its High Time the Australian Government Takes Steps against Diabetes 2
Very fine, blunt tip....
... Designed to meet the ... of cardiology practices. The ... attenuation correction accessory features ... array that increases the ...
Stainless steel lancet blade in stainless steel....
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
Medicine Products: